£50.00

It has never been this cheap. We have no record of a lower price.

£50 today · cheaper than every other day in the last 3 months

ÉDITIONS UNIVERSITAIRES EUROPÉENNES Prévention du cancer du col de l’utérus: Intérêts des analyses morphologiques, immunohistochimiques et moléculaires (Omn.Univ.Europ.)

View at Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 56 days · 56 data points (no recent data)

Historical
Generating forecast…
£50.00 £47.50 £48.50 £49.50 £50.50 £51.50 £52.50 25 July 2026 07 August 2026 21 August 2026 04 September 2026 18 September 2026
View at Amazon ↗

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 56 days • 1 price levels

Days at Price
56 days 0 14 28 42 56 £50 Days at Price

Price Analysis

Most common price: £50 (56 days, 100.0%)

Price range: £50 - £50

Price levels: 1 different prices over 56 days

Description

Le cancer du col de l’utérus occupe le deuxième rang des cancers féminins dans le monde en termes d’incidence et de mortalité, principalement dans les pays en voie de développement. Au Maroc, le cancer du col utérin pose un problème majeur de santé publique. Le nombre de cancer du col utérin survenant annuellement sur l’ensemble des 5 centres d’oncologie publiques et privés (Rabat et Casablanca) est estimé à 6000 dont 2250 sont traités. Le cancer du col de l’utérus est considéré comme une maladie sexuellement transmissible étroitement liée à l’infection par les types 16 et 18 des papillomavirus humains responsables de 70% de ces cancers. La prévention de l’infection par le HPV grâce à la vaccination et le dépistage des lésions précancéreuses semblent donc constituer des priorités auxquelles notre travail a le mérite de s’adresser, et pour la première fois à notre connaissance, à travers l’analyse de plusieurs séries marocaines dont la plupart ont été colligées dans le laboratoire d’anatomie pathologique de l’Institut National d’Oncologie de Rabat.

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
09 December 2011
Listed Since
12 December 2011

Barcode

No barcode data available

Similar Products You Might Like

Cancer Du Col De L’utérus Et L’infection Par Papillomavirus Humain
97% match

Cancer Du Col De L’utérus Et L’infection Par Papillomavirus Humain

ÉDITIONS UNIVERSITAIRES EUROPÉENNES

£49.00 26 Sep 2026
Topics on Cervical Cancer With an Advocacy for Prevention
97% match

Topics on Cervical Cancer With an Advocacy for Prevention

IntechOpen

£119.00 01 Oct 2026
L'antigène CD34 et le stroma du col de l'utérus: Étude clinicopathologique du rôle de l'expression de l'antigène CD34 dans les lésions précancéreuses et malignes du col de l'utérus
97% match

L'antigène CD34 et le stroma du col de l'utérus: Étude clinicopathologique du rôle de l'expression de l'antigène CD34 dans les lésions précancéreuses et malignes du col de l'utérus

£62.00 04 Sep 2026
Recent Topics on Prevention, Diagnosis, and Clinical Management of Cervical Cancer (Comprehensive Gynecology and Obstetrics)
97% match

Recent Topics on Prevention, Diagnosis, and Clinical Management of Cervical Cancer (Comprehensive Gynecology and Obstetrics)

Springer

£94.68 24 Sep 2026
Cervical Cancer: Recent Advances and New Perspectives
97% match

Cervical Cancer: Recent Advances and New Perspectives

IntechOpen

£95.00 22 Sep 2026
Strategies for Overcoming Chemotherapy Resistance in Cervical Cancer: From Molecular Insights to Precision Solutions (Volume 21) (Cancer Sensitizing Agents for Chemotherapy, Volume 21)
97% match

Strategies for Overcoming Chemotherapy Resistance in Cervical Cancer: From Molecular Insights to Precision Solutions (Volume 21) (Cancer Sensitizing Agents for Chemotherapy, Volume 21)

Elsevier

£124.00 03 Oct 2026
High-Risk Human Papillomavirus and Cervical Carcinoma: A Study on Human Papillomavirus: High-Risk E6, p53 and p16 Proteins Expression and Their Role in Cervical Carcinogenesis
97% match

High-Risk Human Papillomavirus and Cervical Carcinoma: A Study on Human Papillomavirus: High-Risk E6, p53 and p16 Proteins Expression and Their Role in Cervical Carcinogenesis

LAP Lambert Academic Publishing

£48.00 27 Sep 2026
The Resistance of Cervical Cancer to Chemotherapy and its Reversal (Volume 9) (Breaking Tolerance to Anti-Cancer Cell-Mediated Immunotherapy, Volume 9)
96% match

The Resistance of Cervical Cancer to Chemotherapy and its Reversal (Volume 9) (Breaking Tolerance to Anti-Cancer Cell-Mediated Immunotherapy, Volume 9)

Elsevier

£125.15 19 Sep 2026
What Every Woman Should Know about Cervical Cancer: Revised and Updated
96% match

What Every Woman Should Know about Cervical Cancer: Revised and Updated

Springer

£107.47 18 Sep 2026
The 2023-2028 Outlook for Cervical Cancer Treatments in the United States
96% match

The 2023-2028 Outlook for Cervical Cancer Treatments in the United States

£520.00 25 Aug 2026
The 2023-2028 Outlook for Cervical Cancer Diagnostic Testing in the United States
96% match

The 2023-2028 Outlook for Cervical Cancer Diagnostic Testing in the United States

£520.00 02 Oct 2026
The 2023-2028 Outlook for Cervical Cancer Treatments in Japan
96% match

The 2023-2028 Outlook for Cervical Cancer Treatments in Japan

£495.00 16 Aug 2026
The 2023-2028 Outlook for Cervical Cancer Treatments in India
96% match

The 2023-2028 Outlook for Cervical Cancer Treatments in India

£515.00 23 Aug 2026
The 2023-2028 Outlook for Cervical Cancer Diagnostic Testing in India
96% match

The 2023-2028 Outlook for Cervical Cancer Diagnostic Testing in India

£515.00 03 Oct 2026
Cervical Cancer: A Global Public Health Treatise
96% match

Cervical Cancer: A Global Public Health Treatise

IntechOpen

£119.00 25 Sep 2026
The 2023-2028 Outlook for Cervical Cancer Treatments in China
96% match

The 2023-2028 Outlook for Cervical Cancer Treatments in China

£495.00 23 Aug 2026
Open, Laparoscopic, and Robotic Surgery for Cervical Cancer
96% match

Open, Laparoscopic, and Robotic Surgery for Cervical Cancer

Springer

£80.67 18 Sep 2026
Preventive screening for cervical cancer among low-income patients: Use of Pap smear screening among low-income patients
96% match

Preventive screening for cervical cancer among low-income patients: Use of Pap smear screening among low-income patients

LAP Lambert Academic Publishing

£57.00 07 Oct 2026
The 2023-2028 World Outlook for Cervical Cancer Treatments
96% match

The 2023-2028 World Outlook for Cervical Cancer Treatments

£795.00 27 Aug 2026
Colposcopy of Female Genital Tract - Springer Medical Reference
96% match

Colposcopy of Female Genital Tract - Springer Medical Reference

Springer

£92.82 05 Oct 2026
Cervical Cancer: From Etiology to Prevention: 2 (Cancer Prevention-Cancer Causes, 2)
96% match

Cervical Cancer: From Etiology to Prevention: 2 (Cancer Prevention-Cancer Causes, 2)

Springer

£95.00 22 Aug 2026
Modern Approach to Colposcopic Findings: Atlas for the Practitioner in Gynaecology
96% match

Modern Approach to Colposcopic Findings: Atlas for the Practitioner in Gynaecology

De Gruyter

£123.50 19 Sep 2026
The 2023-2028 Outlook for Cervical Cancer Treatments for US Zip Codes
96% match

The 2023-2028 Outlook for Cervical Cancer Treatments for US Zip Codes

£490.00 26 Aug 2026
Cervical Cancer
96% match

Cervical Cancer

Springer

£117.61 01 Oct 2026